To produce disease, viruses must enter the host, multiply locally in host tissues, spread from the site of entry, and overcome or evade host immune responses. At each stage in this infectious process, specific microbial and host genes determine the ultimate virulence of the virus. Genetic approaches have identified many viral genes that play critical roles in virulence and are presumed to target specific components of the host innate and acquired immune response. However, formal proof that a virulence gene targets a specific protein in a host pathway in vivo has not been obtained. 
I
FNs are key components of host innate immunity to virus infection that act through several pathways to block virus growth and virulence (refs. 1-3; Fig. 1 ). We considered the hypothesis that the ICP34.5 gene of herpes simplex virus type 1 (HSV-1) inactivates a specific component of IFN responses in vivo. This hypothesis is based on the observations that ICP34.5 inhibits the IFN-induced double-stranded RNA-dependent protein kinase R (PKR) system in cell culture ( Fig. 1; refs. [4] [5] [6] and that viruses lacking ICP34.5 are profoundly attenuated in vivo (7, 8) . Activation of PKR leads to phosphorylation of the ␣-subunit of eukaryotic initiation factor 2␣ (eIF-2␣) and a subsequent shutdown of host and viral protein synthesis and replication ( Fig.  1 ; refs. 9 and 10). In addition, PKR phosphorylates IB and activates NF-B, transcription factors that may contribute to IFN-dependent antiviral effects (11) . The hypothesis that ICP34.5 targets PKR-dependent responses is attractive, because ICP34.5 binds to a protein phosphatase and causes it to dephosphorylate eIF-2␣, thereby potentially negating the antiviral effects of PKR ( Fig. 1 
; refs. 2 and 12).
We previously demonstrated that an HSV-1 mutant in gene ICP34.5 grew to normal levels and showed wild-type virulence in mice lacking both type 1 (IFN-␣␤) and type 2 (IFN-␥) IFN receptors (IFN-␣␤␥R Ϫ͞Ϫ ). These results were obtained despite the fact that, in normal mice, the mutant had a 10,000-fold reduction in replication and neurovirulence (13) . The restoration of a normal phenotype to the ICP34.5 mutant by deletion of IFN receptors was consistent with the hypothesis that some aspect of IFN action in vivo is the primary target of the ICP34.5 gene. Deletion of IFN receptors, however, also resulted in increased replication in mice of HSVs with null mutations in the ICP0, thymidine kinase (tk), ribonucleotide reductase, and virion host shutoff (vhs) genes. Increased viral replication in vivo resulting from loss of IFN receptors was therefore not a specific property of viruses lacking ICP34. 5 .
We determined that three criteria must be met to validate the hypothesis that ICP34.5 blocks PKR-dependent antiviral effects in vivo and that this interaction is pivotal for neurovirulence. First, an ICP34.5-deleted virus must show restored growth and virulence in mice lacking PKR (PKR Ϫ͞Ϫ mice). Second, the growth and virulence of an ICP34.5-deleted virus must not be restored in mice lacking IFN-inducible antiviral pathways that are independent of PKR. Third, HSV strains with mutations in genes other than ICP34.5 must remain attenuated in PKR Ϫ͞Ϫ mice. In this study, we test and meet these three criteria, showing that a virus that has been attenuated by deletion of ICP34.5 has wild-type replication and virulence in a host from which the PKR gene has been deleted. This specific phenotypic restoration both defines a key molecular target of ICP34.5 in vivo and provides the genetic criteria for determining mechanisms of microbial virulence in vivo.
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Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073͞pnas.100415697. Article and publication date are at www.pnas.org͞cgi͞doi͞10.1073͞pnas.100415697 Fig. 1 . IFN-mediated induction of the antiviral state through independent pathways by RNase L and PKR. For RNase L, IFNs interacting with their receptors lead to expression of 2-5A synthetase, which, after double-stranded RNA binding, produces 2Ј,5Ј-oligoadenylates that lead to RNase L activation and blockage of viral replication. IFN also induces expression of PKR, which is also activated through double-stranded RNA binding. One of the activities of PKR is to phosphorylate eIF-2␣ leading to cessation of protein synthesis and blockage of viral replication. To evade this antiviral mechanism, HSV-1 ICP34.5 binds to protein phosphatase 1␣ and dephosphorylates eIF-2␣, lifting the block on viral replication. Mice with null mutations in the IFN receptors, RNase L, and PKR (gray boxes) were used in this study to dissect the interaction of ICP34.5 with these pathways.
Materials and Methods
Viruses and Cells Vero. (African green monkey kidney) cells were propagated, and growth and assay of all virus strains were done as described (14 Animal Procedures. Mice 6-8 weeks old were anesthetized with xylazine and ketamine. Corneas were scarified with 10 interlocking strokes with a 27-gauge needle, and 5 l of medium containing 2 ϫ 10 4 or 2 ϫ 10 6 plaque-forming units (pfu) of virus was added per eye. Lids were massaged together briefly to promote adsorption of virus. Eye swab and trigeminal ganglion assays of acute infection were performed as described (15) . Briefly, for eye swabs, eyes were proptosed, and moistened cotton swabs were used to sample the surface of the eye, going three times in a circular fashion around the eye and twice across the eye making an ''X'', before placing the swab in 1 ml of tissue culture medium. Sampled trigeminal ganglia were homogenized in 1 ml of tissue culture medium by using 1-mm beads in a MiniBeadbeater-8 (Biospec Products, Bartlesville, OK). All samples were titered by standard plaque assay on Vero cells. All data presented are logarithmic means Ϯ SEM, and the limit of detection was 10 pfu. Intracerebral inoculations were performed essentially as described (15) . In brief, mice were inoculated intracerebrally with 20 l of virus inoculum containing the appropriate virus, and time to death was recorded. All mouse procedures conformed to protocols approved by the Washington University Animal Studies Committee.
Results
Specific Normalization of Growth of an ICP34.5 ؊ Virus in PKR ؊͞؊ Mice.
We examined the replication of an ICP34.5 mutant in PKR Ϫ͞Ϫ mice and used strain 129͞B6 F 1 hybrid mice as wild-type controls. All 129 and 129͞B6 strain mice used in this study were bred in the 129 line, the same 129 line as was used to generate the PKR Ϫ͞Ϫ and IFN-␣␤␥R Ϫ͞Ϫ mice. This manner of breeding was done to avoid any possible bias in the data caused by variation among 129 strains (19) . As a positive control, we infected IFN-␣␤␥R Ϫ͞Ϫ mice, which lack activation of the entire IFN pathway, alongside strain 129 mice as wild-type controls ( Fig. 1) . As a control for host resistance-gene specificity, we also tested the hypothesis that RNase L is the target of ICP34. The various wild-type strains and PKR
Ϫ͞Ϫ
, IFN-␣␤␥R Ϫ͞Ϫ , and RNase L Ϫ͞Ϫ mice were infected via the cornea with the attenuated ICP34.5 mutant 17TermA (termed here ⌬34.5) or its marker-rescued virus 17TermAR (termed here control virus), which has wild-type growth and virulence. Viral replication was measured in corneal epithelia and in trigeminal ganglia (Fig. 2) . In all wild-type mouse strains, replication of ⌬34.5 was significantly (P Ͻ 0.01) reduced in eyes by up to 1,000-fold relative to that of control virus (Fig. 2 A, C, and E) . These results are consistent with those obtained with mice and rabbits, which have been published (23, 24) . In PKR Ϫ͞Ϫ and IFN-␣␤␥R Ϫ͞Ϫ mice, however, replication of ⌬34.5 in corneas was statistically indistinguishable (P ϭ 0.84 and P ϭ 0.27) from that of control virus ( Fig. 2 B and D) . In contrast, in RNase L Ϫ͞Ϫ mice, the attenuation of replication of ⌬34.5 remained significant (P Ͻ 0.02) relative to control virus (Fig. 2F) . A similar pattern was observed during acute infection in trigeminal ganglia (Fig. 3) . Growth of ⌬34.5 was almost undetectable in ganglia of RNase L Ϫ͞Ϫ and all wild-type mouse strains but was restored to control virus levels in PKR Ϫ͞Ϫ and IFN-␣␤␥R Ϫ͞Ϫ mice. Thus, null mutation in PKR, but not RNase L, restored normal growth of a virus lacking ICP34.5, thereby meeting the first and second criteria stated above.
Normalization of Growth by Deletion of PKR Is Specific to Viruses
Lacking ICP34.5. We considered the possibility that PKR is key for antiviral effects of IFN against all attenuated viruses whose replication can be enhanced significantly in mice lacking the IFN receptors. Two other attenuated viruses, the thymidine kinase (tk) null mutant dl8.36tk (termed ⌬tk) and the virion host shutoff (vhs) null mutant UL41NH (termed here ⌬vhs), were therefore used as controls for the specificity of the ICP34.5-PKR relationship. Replication of ⌬tk and ⌬vhs in corneas and ganglia of wild-type mice was reduced relative to KOS (Fig. 4 A and D) . In corneas and trigeminal ganglia of IFN-␣␤␥R Ϫ͞Ϫ mice, replication of ⌬tk and ⌬vhs was enhanced, although not restored completely (Fig. 4 B and D) . In contrast, deletion of PKR did not (P Ͼ 0.05) enhance the growth of either virus significantly (Fig.  4 C and D) , in striking contrast to results obtained with ⌬34.5 ( Figs. 1 and 2 ). Both of these mutants (⌬tk and ⌬vhs), however, are in the background of HSV-1 KOS, whereas ⌬34.5 and its control virus are in the background of strain 17 syn ϩ . We therefore considered the hypothesis that the lack of phenotypic restoration of ⌬tk and ⌬vhs was due to these viruses being in the background of a different, less virulent strain. To address this hypothesis, PKR Ϫ͞Ϫ and 129͞B6 mice were infected with a tk mutant (termed 17⌬tk) or marker-rescued virus (termed ⌬tk17R) made in the background of strain 17 syn ϩ , the same background as ⌬34.5 and its control virus. In corneas and trigeminal ganglia (Fig. 4 E-G) , the replication of 17⌬tk was not enhanced in PKR Ϫ͞Ϫ mice compared with that in 129͞B6 control mice. This result demonstrated that deletion of PKR reverses the growth-deficient phenotype of the ICP34.5 mutant and does not result in a generalized increase in growth of all attenuated viruses, thereby meeting the third of the criteria stated above.
Specific Normalization of Virulence of an ICP34.5 ؊ Virus in PKR ؊͞؊
Mice. In addition to reduced growth, HSV strains lacking ICP34.5 are 10 4 -to 10 6 -fold less neurovirulent than control viruses as measured by lethality to mice after corneal or intracerebral (i.c.) infection (7, 8) . We reasoned, therefore, that if ICP34.5 negates PKR in vivo, the removal of PKR from mice should restore lethality completely to the ⌬34.5 virus. The virulence of ⌬34.5 and the control virus was therefore assessed by measuring survival of mice after i.c. or corneal infection. Given that the activation and antiviral activity of PKR depend on IFNs and their receptors, we first assessed the lethality of ⌬34.5 and the control virus after i.c. infection of IFNR Ϫ͞Ϫ mice. After i.c. injection with the control virus, 100% of 129 wild-type, IFN-␣␤R Ϫ͞Ϫ , and IFN-␣␤␥R Ϫ͞Ϫ mice died within 4 days of infection (Fig. 5A) . Infection of IFN-␣␤R Ϫ͞Ϫ and IFN-␣␤␥R Ϫ͞Ϫ mice with ⌬34.5 resulted in 100% death within 3 days of infection but only 20% death of 129 wild-type mice (Fig. 5B) . Similar data were obtained after infection of PKR Ϫ͞Ϫ mice. After i.c. injection with the control virus, 100% of 129͞B6 wild-type and PKR Ϫ͞Ϫ mice died within 6 days of infection (Fig. 5C ). After i.c. injection with the ⌬34.5 virus, 100% of PKR Ϫ͞Ϫ mice died within 5 days of infection, but none of the 129͞B6 wild-type mice died (Fig. 5D) . All of the aforementioned experiments were performed in duplicate with an input dose of 2 ϫ 10 4 pfu. Identical results were obtained in multiple experiments performed at a We considered the hypothesis that deletion of other IFNdependent antiviral pathways, independent of PKR, could restore virulence to ⌬34.5. We therefore examined the virulence of ⌬34.5 and control virus in RNase L Ϫ͞Ϫ mice (Fig. 6) . Control virus killed all mice (RNase L Ϫ͞Ϫ or C57BL͞6J wild type) within 10 days (Fig. 6A) . In contrast, all mice survived after infection with ⌬34.5 (Fig. 6B) . This result showed that ICP34.5-dependent neurovirulence could not be restored via deletion of RNase L. We considered a further caveat that deletion of PKR could restore virulence to attenuated viruses lacking genes other than ICP34.5. To test this caveat, PKR Ϫ͞Ϫ and wild-type mice were i.c. infected with an avirulent recombinant virus lacking tk (17⌬tk) and a marker-rescued control virus (17⌬tkR). Both viruses were in the background of HSV-1 strain 17 syn ϩ and therefore isogenic with ⌬34.5. After injection of 17⌬tkR, 100% of PKR Ϫ͞Ϫ and 80% 129͞B6 mice died, whereas no mice died after injection of 17⌬tk (Fig. 6 C and D) . These data show that deletion of PKR does not restore virulence to a virus lacking a gene unrelated to ICP34.5.
Finally, we wished to examine whether the restoration of virulence to ⌬34.5 by deletion of PKR could be demonstrated by using a more physiological route of infection, via the periphery. After corneal infection with the control virus, survival kinetics of wild-type or PKR Ϫ͞Ϫ mice were indistinguishable with 70-90% of mice dying within 21 days (Fig. 7A) . In contrast, none of the wild-type mice died after ⌬34.5 infection, but 90% of the PKR Ϫ͞Ϫ mice infected with ⌬34.5 died within 21 days (Fig. 7B) . The restoration of virulence is therefore independent of the route of infection. In addition, the similarity of the survival curves for the wild-type and PKR Ϫ͞Ϫ mice infected with the control virus indicates that ICP34.5 is a highly efficient inactivator of the antiviral effects of PKR. Taken together, these data show that deletion of PKR or IFN receptors, but not RNase L, reverses the attenuated virulence phenotype of the ⌬34.5 mutant and that phenotypic restoration is specific to viruses lacking ICP34.5.
Discussion
Our results show the feasibility of a dual genetic approach involving mutagenesis of both pathogen and host for the definition of pathways and precise molecular targets in disease. We therefore propose three general criteria for such future definitions. First, the attenuation of the specifically mutated virus must be restored in terms of growth and virulence in a host lacking the target of the mutated viral gene. Second, the growth and virulence of the specifically mutated virus must not be restored in a host lacking other viral resistance pathways that are independent of the pathway in question. Third, attenuated viral strains with mutations in genes irrelevant to the one in question must remain attenuated in a host deleted of the resistance factor being analyzed. The second and third criteria are especially important for proof of specificity. They ensure that the particular deficient host does not restore every attenuated virus to full virulence and that the restoration of virulence in that host is specific to a particular virulence determinant. It should be noted that three criteria for proof that a gene has immunoregulatory function have been suggested previously (25) . These were, first, that mutation of the viral gene should not affect growth in vitro. Second, a targeted revertant of the recombinant virus should Survival of wild-type 129 and PKR-deficient mice after corneal infection. Survival of wild-type 129 (closed squares) and PKR-deficient (open triangles) mice is shown for control virus (A) and ⌬34.5 (B). At least 10 mice were used over two experiments to generate each curve. Control virus and ⌬34.5 are both in the background of strain 17. display no phenotypic difference from wild type. This particular criterion is the accepted standard for studies of viral genetics in which marker rescue of the mutated virus is performed to ensure that its phenotype is due only to the intended mutation and not due to some secondary unanticipated mutation. This criterion was met for all mutant viruses used in this study. Third, attenuation caused by the lack of the immunomodulatory function should be phenotypically complemented in a host that is unable to exert the resistance that is targeted by the mutated viral gene. Our studies reported herein therefore complement and significantly extend these previous criteria in providing important genetic criteria for determining mechanisms of microbial virulence in vivo.
We included controls to address two additional important issues, the possible contribution of virus strain and mouse strain to our observed results. By including the attenuated mutant virus 17⌬tk, constructed in the same background (strain 17syn ϩ ) as the ⌬34.5 mutant under study, we ruled out the possibility that deletion of PKR restores virulence to all strain 17-derived viruses. We also considered the hypothesis that the restoration of growth and virulence to ⌬34.5 in PKR Ϫ͞Ϫ mice was due to a secondary host gene differing between 129 and B6 mouse strains. We observed, however, that ⌬34.5 is attenuated in 129, B6, and 129͞B6 F 1 hybrids, indicating that there is no gene or combination of genes that can normalize the growth or virulence of the ⌬34.5 virus. This finding allows us to conclude that deletion of PKR is specifically responsible for restoration of the attenuated phenotype of the ICP34.5 mutant virus.
A number of previous studies have been performed in which the reversal of attenuation of viruses lacking certain virulence genes has been attempted or accomplished by removal or depletion of the presumed host targets of such virulence genes (25) (26) (27) (28) (29) . In one of these studies (26) , it was shown that an attenuated murine cytomegalovirus strain lacking the Fc receptor gene did not show the expected restoration of virulence in antibody-deficient mice, indicating the necessity for careful in vivo genetic analysis of host-pathogen interactions. Other studies have successfully shown restoration of virulence of murine cytomegalovirus and HSV-1 mutants but did not fulfill the second and third criteria listed above, thereby lacking absolute evidence of the specificity of viral-host factor interactions in question (25, 27, 29) . In contrast, all criteria were met in a study in which the virulence of an HSV-1 ICP47-deficient virus, but not a glycoprotein E-deficient virus, was restored by depletion of CD8 ϩ , but not CD4 ϩ T cells (28) , although the specific pathways presumably targeted by ICP47, the TAP transporters, were not mutated in the animals used. In this study, we have shown that deletion of PKR, but not RNase L, reversed the attenuated phenotype of an HSV-1 ICP34.5 null mutant with restoration of both growth and neurovirulence. The growth and virulence of null mutants in unrelated viral virulence genes were not restored in PKR-deficient mice. This result is in contrast to previous results with IFN receptor-deficient mice in which the growth of several mutants was enhanced significantly (13) . Loss of PKR therefore does not nonspecifically restore virulence to all attenuated viruses. Furthermore, we demonstrated that the lack of PKR pathway in the host did not result in enhanced replication or virulence of the control virus. This demonstration implies that ICP34.5 is a highly efficient inactivator of the antiviral effects of PKR. These data formally show that the PKR pathway is the specific target for ICP34.5 in vivo and verify the mechanism by which ICP34.5 mutants are attenuated.
